These results for orthotopic Rb tumors corroborate our in-vitro data showing increased survivin expression in Rb cells exposed to carboplatin as well as decreased survivin expression when carboplatin was combined with YM155. This evidence concerns the gene BIRC5 and retinoblastoma.